% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • dctrig dctrig Dec 1, 2010 2:52 PM Flag

    Talley's Mixed Message Take on FDA Discussions

    Per yesterday's presentation:

    POSITIVE - FDA has backtracked on requiring Epicept to prove that Ceplene is efficacious independent of interleukin-2 (IL-2.

    NEGATICE - FDA has "moved the goal post" and now requires proof of overall survival benefit.

0.292+0.012(+4.25%)Sep 26 4:00 PMEDT